Is Gilead Sciences Getting Ready for a Massive Acquisition?
Sinking earnings. Horrible outlook for this year. Perhaps the big biotech needs to develop an antidepressant -- just to give to its shareholders.
from Biotech News
Sinking earnings. Horrible outlook for this year. Perhaps the big biotech needs to develop an antidepressant -- just to give to its shareholders.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments